Artificial Intelligence
Global Antimicrobial Susceptibility Testing Market to Reach $5.2 Million by 2030
<!– Name:DistributionId Value:8740706 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1199811 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:ff404679-7644-4544-80dd-8ad2f151cc8b –>
New York, Feb. 01, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Antimicrobial Susceptibility Testing Industry” – https://www.reportlinker.com/p05797901/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Antimicrobial Susceptibility Testing Market to Reach $5.2 Million by 2030
In the changed post COVID-19 business landscape, the global market for Antimicrobial Susceptibility Testing estimated at US$3.6 Million in the year 2022, is projected to reach a revised size of US$5.2 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. Manual Products, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$1.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Automated Laboratory Instruments segment is readjusted to a revised 4.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $970.5 Thousand, While China is Forecast to Grow at 8.2% CAGR
The Antimicrobial Susceptibility Testing market in the U.S. is estimated at US$970.5 Thousand in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$710.4 Thousand by the year 2030.
Select Competitors (Total 52 Featured)
– Accelerate Diagnostics, Inc.
– Alifax SpA
– Becton, Dickinson and Company
– Bioanalyse Tibbi Malz. San. ve Tic. Ltd. Sti.
– bioMerieux SA
– Bio-Rad Laboratories, Inc.
– Creative Diagnostics
– HiMedia Laboratories
– Liofilchem S.r.l.
– Merck KGaA
– Merlin Diagnostica GmbH
– Synbiosis
– Thermo Fisher Scientific, Inc.
– Zhuhai Dl Biotech Co., Ltd.
Read the full report: https://www.reportlinker.com/p05797901/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
COVID-19 Pandemic Impact and the Global Economic Update
War & Inflation Supersede COVID-19 as Major Downside Risks for
the Global Economy in 2023 & Beyond
Here’s How Inflationary Pressures Affect the Economy
Russia-Ukraine War, the Primary Culprit Responsible for the
Hardships
Stubbornly High Inflation to Single Handedly Drag Down Global
Growth
Here’s What’s Causing the Current Spike in Inflation
Shaken by the War, Global Oil Prices Spiral and Feed
Inflationary Pressures, Guiding the World towards a Cost of
Living Crisis: Global Average Annual Brent Crude Oil Price:
( In US$ Per Barrel) for Years 2017 through 2023
War-Induced Commodity Price Increases & Broad Based Price
Pressures Mark the Return of Global Inflation in 2022 to the
Highest Level Seen Since 1996: Global Inflation Rates (In %)
for the Years 2019 Through 2024
War, Global Inflation, Cost of Living Crisis, Failed Fiscal
Policy Attempts to Restore Price Stability & Contain Downside
Risks to Result in Sharper-Than-Expected Slowdown in Global
Economic Growth: World Economic Growth Projections (Real
GDP, Annual % Change) for the Years 2020, 2021, 2022 and
2023
Recession Triggered by Uncontrolled Inflation or Unemployment,
Which is the Greater Evil? Inflation Battling Policy Measures
to Slowdown Post Pandemic Recovery in Unemployment Rates:
Global Number of Unemployed People (In Million) for Years
2019 Through 2023
Pandemic Impact on Antimicrobial Susceptibility Testing Market
An Introduction to Antimicrobial Susceptibility Testing
Antibiotic Sensitivity Testing Methods
Global Market Prospects & Outlook
Segment Analysis
Developed Regions Lead, Promising Growth in Store Across
Developing Economies
Competition
Antimicrobial Susceptibility Testing – Global Key Competitors
Percentage Market Share in 2024 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
Players Worldwide in 2024 (E)
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Infectious Diseases & Overuse of
Antibiotics Fuel Demand for Antimicrobial Susceptibility
Testing
Infectious Diseases Remain Major Cause of Death in Under
Developed Regions: Breakdown of Leading Causes of Death in
Sub-Saharan Africa (in %)
Infectious Diseases Related Mortality High Among Children Below
5 Years: Breakdown of Leading Causes of Death in Children
Below 5 Years (in %)
Rise in Prevalence of Respiratory Infections Drive Market Growth
Global Number of Deaths Caused Due to Communicable Diseases (In
000s)
Antimicrobial Susceptibility Testing Finds Growing Acceptance
in Clinical Diagnostics
Growing Use of Antimicrobial Susceptibility Testing by
Biopharma Companies Boosts Market Prospects
Pharmaceutical R&D Spending Worldwide (US$ Billion): 2015-2022
Increasing Need to Reduce Hospital Acquired Infections Presents
Growth Opportunities
Leading Nosocomial Infections in the US: Percentage Breakdown
of Healthcare Cost by Infection Type
Government Initiatives for the Detection & Control of
Antimicrobial Resistant Species Augurs Well for the Market
AST to Play a Critical Part in Regulating Development of
Antimicrobial Resistances
Introduction of Digital Technologies Streamlines Process
Associated with Developing Vaccines
AST Technologies Helping Accelerate Targeted Antimicrobial Therapy
Antimicrobial Susceptibility Testing Plays Key Role in Medical
Decision Making
rAST: Accelerating the Process of Antimicrobial Susceptibility
Testing
Faster Antibiotic Susceptibility Tests Become Vital for High-
Priority Pathogens
Digital Technologies Help in Rapid Antimicrobial Susceptibility
Testing
Emerging AST Methods to Facilitate Wider Adoption
Rapidly Evolving Bacterial Pathogens and the Role of Rapid POC
AST Diagnostics
Demand for Digital Medical Devices Bodes Well for the Market
Development of AST Standards to Enable Responsible
Antimicrobials Usage
Antimicrobial Susceptibility Test Breakpoints
Advent of Innovative Technologies Foster Growth for
Antimicrobial Susceptibility Testing Market
Use of Artificial Intelligence-Based Applications Exhibits a Surge
Novel Tools Focus on Antibiotic-Resistant Microbes
Researchers Develop Novel Methods to Acquire Outcomes on
Susceptibility of Bacteria
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Antimicrobial Susceptibility Testing Market
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2030
Table 2: World Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 3: World Historic Review for Antimicrobial Susceptibility
Testing by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 4: World 16-Year Perspective for Antimicrobial
Susceptibility Testing by Geographic Region – Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for
Manual Products by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 6: World Historic Review for Manual Products by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 7: World 16-Year Perspective for Manual Products by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Automated Laboratory Instruments by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for Automated Laboratory
Instruments by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 10: World 16-Year Perspective for Automated Laboratory
Instruments by Geographic Region – Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for
Culture & Growth Media by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Culture & Growth Media by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 13: World 16-Year Perspective for Culture & Growth Media
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
Consumables by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Consumables by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 16: World 16-Year Perspective for Consumables by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for
Antibacterial by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Antibacterial by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 19: World 16-Year Perspective for Antibacterial by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Antifungal by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Antifungal by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 22: World 16-Year Perspective for Antifungal by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for
Antiparasitic by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Antiparasitic by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 25: World 16-Year Perspective for Antiparasitic by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Other Testing Types by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Other Testing Types by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Other Testing Types by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in the United States
for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Antimicrobial Susceptibility
Testing by Product – Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Antimicrobial Susceptibility
Testing by Testing Type – Antibacterial, Antifungal,
Antiparasitic and Other Testing Types Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 34: USA 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 36: Canada Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 37: Canada 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 38: Canada Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 40: Canada 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
JAPAN
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Japan for 2023 (E)
Table 41: Japan Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 42: Japan Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 43: Japan 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 44: Japan Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 45: Japan Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 46: Japan 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
CHINA
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in China for 2023 (E)
Table 47: China Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 48: China Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 49: China 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 50: China Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 51: China Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 52: China 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
EUROPE
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Europe for 2023 (E)
Table 53: Europe Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Geographic Region –
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Antimicrobial
Susceptibility Testing by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Antimicrobial
Susceptibility Testing by Geographic Region – Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 57: Europe Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 58: Europe 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 59: Europe Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 61: Europe 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
FRANCE
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in France for 2023 (E)
Table 62: France Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 63: France Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 64: France 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 65: France Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 66: France Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 67: France 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
GERMANY
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in Germany for 2023 (E)
Table 68: Germany Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 69: Germany Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 70: Germany 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 71: Germany Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 72: Germany Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 73: Germany 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
ITALY
Table 74: Italy Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 75: Italy Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 76: Italy 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 77: Italy Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 78: Italy Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 79: Italy 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
UNITED KINGDOM
Antimicrobial Susceptibility Testing Market Presence – Strong/
Active/Niche/Trivial – Key Competitors in the United Kingdom
for 2023 (E)
Table 80: UK Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 81: UK Historic Review for Antimicrobial Susceptibility
Testing by Product – Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 82: UK 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 83: UK Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 84: UK Historic Review for Antimicrobial Susceptibility
Testing by Testing Type – Antibacterial, Antifungal,
Antiparasitic and Other Testing Types Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 85: UK 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
SPAIN
Table 86: Spain Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 87: Spain Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 88: Spain 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 89: Spain Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 90: Spain Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 91: Spain 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
RUSSIA
Table 92: Russia Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Russia Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 94: Russia 16-Year Perspective for Antimicrobial
Susceptibility Testing by Product – Percentage Breakdown of
Value Sales for Manual Products, Automated Laboratory
Instruments, Culture & Growth Media and Consumables for the
Years 2014, 2023 & 2030
Table 95: Russia Recent Past, Current & Future Analysis for
Antimicrobial Susceptibility Testing by Testing Type –
Antibacterial, Antifungal, Antiparasitic and Other Testing
Types – Independent Analysis of Annual Sales in US$ Thousand
for the Years 2022 through 2030 and % CAGR
Table 96: Russia Historic Review for Antimicrobial
Susceptibility Testing by Testing Type – Antibacterial,
Antifungal, Antiparasitic and Other Testing Types Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 97: Russia 16-Year Perspective for Antimicrobial
Susceptibility Testing by Testing Type – Percentage Breakdown
of Value Sales for Antibacterial, Antifungal, Antiparasitic and
Other Testing Types for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 98: Rest of Europe Recent Past, Current & Future Analysis
for Antimicrobial Susceptibility Testing by Product – Manual
Products, Automated Laboratory Instruments, Culture & Growth
Media and Consumables – Independent Analysis of Annual Sales in
US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 99: Rest of Europe Historic Review for Antimicrobial
Susceptibility Testing by Product – Manual Products, Automated
Laboratory Instruments, Culture & Growth Media and Consumables
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05797901/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
IBM, Government of Canada, Government of Quebec Sign Agreements to Strengthen Canada’s Semiconductor Industry
Up to $187M CAD to be invested to progress expansion of chip packaging capacity and capabilities and to strengthen R&D at IBM Canada’s Bromont plant
BROMONT, QC, April 26, 2024 /PRNewswire/ — IBM (NYSE: IBM), the Government of Canada, and the Government of Quebec today announced agreements that will strengthen Canada’s semiconductor industry, and further develop the assembly, testing and packaging (ATP) capabilities for semiconductor modules to be used across a wide range of applications including telecommunications, high performance computing, automotive, aerospace & defence, computer networks, and generative AI, at IBM Canada’s plant in Bromont, Quebec. The agreements reflect a combined investment valued at approximately $187M CAD.
“Today’s announcement is a massive win for Canada and our dynamic tech sector. It will create high-paying jobs, invest in innovation, strengthen supply chains, and help make sure the most advanced technologies are Canadian-made. Semiconductors power the world, and we’re putting Canada at the forefront of that opportunity,” said the Right Honourable Justin Trudeau, Prime Minister of Canada
In addition to the advancement of packaging capabilities, IBM will be conducting R&D to develop methods for scalable manufacturing and other advanced assembly processes to support the packaging of different chip technologies, to further Canada’s role in the North American semiconductor supply chain and expand and anchor Canada’s capabilities in advanced packaging.
The agreements also allow for collaborations with small and medium-sized Canadian-based enterprises with the intent of fostering the development of a semiconductor ecosystem, now and into the future.
“IBM has long been a leader in semiconductor research and development, pioneering breakthroughs to meet tomorrow’s challenges. With the demand for compute surging in the age of AI, advanced packaging and chiplet technology is becoming critical for the acceleration of AI workloads,” said Darío Gil, IBM Senior Vice President and Director of Research. “As one of the largest chip assembly and testing facilities in North America, IBM’s Bromont facility will play a central role in this future. We are proud to be working with the governments of Canada and Quebec toward those goals and to build a stronger and more balanced semiconductor ecosystem in North America and beyond.”
IBM Canada’s Bromont plant is one of North America’s largest chip assembly and testing facilities, having operated in the region for 52 years. Today, the facility transforms advanced semiconductor components into state-of-the-art microelectronic solutions, playing a key role in IBM’s semiconductor R&D leadership alongside IBM’s facilities at the Albany NanoTech Complex and throughout New York’s Hudson Valley. These agreements will help to further establish a corridor of semiconductor innovation from New York to Bromont.
“Advanced packaging is a crucial component of the semiconductor industry, and IBM Canada’s Bromont plant has led the world in this process for decades,” said Deb Pimentel, president of IBM Canada. “Building upon IBM’s 107-year legacy of technology innovation and R&D in Canada, the Canadian semiconductor industry will now become even stronger, allowing for robust supply chains and giving Canadians steady access to even more innovative technologies and products. This announcement represents just one more example of IBM’s leadership and commitment to the country’s technology and business landscape.”
Chip packaging, the process of connecting integrated circuits on a chip or circuit board, has become more complex as electronic devices have shrunk and the components of chips themselves get smaller and smaller. IBM announced the world’s first 2 nanometer chip technology in 2021 and, as the semiconductor industry moves towards new methods of chip construction, advances in packaging will grow in importance.
“Semiconductors are part of our everyday life. They are in our phones, our cars, and our appliances. Through this investment, we are supporting Canadian innovators, creating good jobs, and solidifying Canada’s semiconductor industry to build a stronger economy. Canada is set to play a larger role in the global semiconductor industry thanks to projects like the one we are announcing today. Because, when we invest in semiconductor and quantum technologies, we invest in economic security.” — The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
“This investment by IBM in Bromont will ensure that Quebec continues to stand out in the field of microelectronics. An increase in production capacity will solidify Quebec’s position in the strategic microelectronics sector in North America.” — The Honourable Pierre Fitzgibbon, Minister of Economy, Innovation and Energy, Minister responsible for Regional Economic Development and Minister responsible for the Metropolis and the Montreal region
About IBMIBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in semiconductors, AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.
Media ContactLorraine BaldwinIBM [email protected]
Willa HahnIBM [email protected]
Photo – https://mma.prnewswire.com/media/2397908/IBM_Canada_employee_at_the_IBM_Bromont_plant_holding_a_wafer.jpg
Logo – https://mma.prnewswire.com/media/95470/ibm_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ibm-government-of-canada-government-of-quebec-sign-agreements-to-strengthen-canadas-semiconductor-industry-302128212.html
Artificial Intelligence
HITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS
HOLLAND, Mich., April 26, 2024 /PRNewswire/ — Hitachi Ltd. (TSE: 6501, “Hitachi”) has signed a stock purchase agreement on April 26 to acquire all shares of MA micro automation GmbH (“MA micro automation”, headquartered in St. Leon-Rot, Germany) from MAX Management GmbH (a subsidiary of MAX Automation SE). MA micro automation is a leading provider of robotic and automation technology (robotic SI) including high-speed linear handling systems, high-precision assembly lines, and high-speed vision inspection technology for Europe, North America, and Southeast Asia, for EUR 71.5M million. The transaction is expected to close in the second half of 2024, pending completion of the customary regulatory filings. After the acquisition is completed, MA micro automation will join JR Automation Technologies, LLC (“JR Automation”), a market leader in providing advanced automation solutions and digital technologies in the robotic system integration business for North America, Europe, and Southeast Asia as a continued effort to expand the company’s global presence.
MA micro automation is a technology leader for automation solutions within micro-assembly. Through its state-of-the-art proprietary high-speed and high-precision automation know-how, combined with unique optical image inspection capabilities, MA micro automation serves high-growth med-tech automation end-markets, covering the production, assembly, and testing medical and optical components including contact lenses, IVD and diabetes diagnostics consumables, and injection molding for medical use. The company was established in 2003 through a carve-out from Siemens*1 and since 2013 has been part of the MAX Automation group.
JR Automation is a leading provider of intelligent automated manufacturing technology solutions, serving customers across the globe in a variety of industries including automotive, life sciences, e-mobility, consumer and industrial products. With over 20 locations between North America, Europe, and Southeast Asia, the leading integrator offers nearly 2 million square feet (185,806 sq. m) of available build and engineering floorspace. This acquisition allows JR Automation to further grow and strengthen both the company’s geographical footprint and their continued commitment on expanding support capabilities within the European region and medical market vertical.
“MA micro automation provides engineering, build and support expertise with established capabilities in complex vision applications, high-speed and high-precision automation technologies. When integrated with JR Automation’s uniform global process and digital technologies, this partnership will further enhance our ability to deliver added value and support to all of our customers worldwide and continue to grow our capabilities in the medical market,” says Dave DeGraaf, CEO of JR Automation. “As we integrate this new dimension, impressive talents and abilities of the MA micro automation team we further enhance our ability to serve our customers, creating a more robust and globally balanced offering.”
With this acquisition, Hitachi aims to further enhance its ability to provide a “Total Seamless Solution*2” to connect manufacturer’s factory floors seamlessly and digitally with their front office data, allowing them to achieve total optimization and bringing Industry 4.0 to life. This “Total Seamless Solution” strategy links organizations’ operational activities such as engineering, supply chain, and purchasing to the plant floor and allows for real time, data-driven decision-making that improves the overall business value for customers.
Kazunobu Morita, Vice President and Executive Officer, CEO of Industrial Digital Business Unit, Hitachi, Ltd. says, “We are very pleased to welcome MA micro automation to the Hitachi Group. The team is based in Europe, providing robotic SI to global medical device manufacturing customers with its high technological capabilities and will join forces with JR Automation and Hitachi Automation to strengthen our global competitiveness. Hitachi aims to enhance its ability to provide value to customers and grow alongside them by leveraging its strengths in both OT, IT, including robotic SI, and “Total Seamless Solution” through Lumada*3’s customer co-creation framework.”
Joachim Hardt, CEO MA micro automation GmbH says, “Following the successful establishment and growth of MA micro automation within the attractive automation market for medical technology products, we are now opening a new chapter. Our partnership with Hitachi will not only strengthen our global competitive position, but we will also benefit from joint technological synergies and a global market presence. We look forward to a synergistic partnership with Hitachi and JR Automation.”
Outline of MA micro automation
Name
MA micro automation GmbH
Head Office
St. Leon-Rot, Germany
Representative
Joachim Hardt (CEO)
Outline of Business
Automation solutions within micro-assembly
Total no. of Employees:
Approx. 200 (As of April 2024)
Founded
2003
Revenues (2023)
€ 46.5 million
Website
*1
“Siemens” is a registered trademark or trademark of Siemens Trademark GmbH & Co. KG in the U.S. and other countries.
*2
“Total Seamless Solution” is a registered trademark of Hitachi, Ltd. in the U.S. and Japan.
*3
Lumada: A collective term for solutions, services and technologies based on Hitachi’s advanced digital technologies for creating value from customers’ data accelerating digital innovation. https://www.hitachi.com/products/it/lumada/global/en/index.html
About JR AutomationEstablished in 1980, JR Automation is a leading provider of intelligent automated manufacturing technology solutions that solve customers’ key operational and productivity challenges. JR Automation serves customers across the globe in a variety of industries, including automotive, life sciences, aerospace, and more.
In 2019, JR Automation was acquired by Hitachi, Ltd. In a strategic effort towards offering a seamless connection between the physical and cyber space for industrial manufacturers and distributers worldwide. With this partnership, JR Automation provides customers a unique, single-source solution for complete integration of their physical assets and data information, offering greater speed, flexibility, and efficiencies towards achieving their Industry 4.0 visions. JR Automation employs over 2,000 people at 21 manufacturing facilities in North America, Europe, and Asia. For more information, please visit www.jrautomation.com.
About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.
Photo – https://mma.prnewswire.com/media/2398552/CENTAURI_IVD_Platform.jpg Logo – https://mma.prnewswire.com/media/2392427/4673549/JR_Automation_and_Hitachi_Combined_Mark_full_color_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hitachi-acquires-ma-micro-automation-of-germany-in-effort-to-accelerate-global-expansion-of-robotic-si-business-in-the-medical-and-other-fields-302128612.html
Artificial Intelligence
$10 million Artificial Intelligence Mathematical Olympiad Prize appoints further advisory committee members
D. Sculley, Kevin Buzzard, Leo de Moura, Lester Mackey and Peter J. Liu appointed to the advisory committee for the Artificial Intelligence Mathematical Olympiad Prize.
LONDON, April 26, 2024 /PRNewswire/ — XTX Markets’ newly created Artificial Intelligence Mathematical Olympiad Prize (‘AIMO Prize’) is a $10mn challenge fund designed to spur the creation of a publicly shared AI model capable of winning a gold medal in the International Mathematical Olympiad (IMO).
XTX Markets is delighted to announce the appointment of five further advisory committee members. This group brings great expertise in machine learning, including D. Sculley, the CEO of Kaggle; Lester Mackey, a Principal Researcher at Microsoft Research and a Macarthur Fellow; and Peter J. Liu, a research scientist at Google DeepMind.
Prolific mathematicians Kevin Buzzard, who achieved a perfect score in the International Mathematical Olympiad, and Leo De Moura who is the Chief Architect for Lean, the automated reasoning tool, also join the advisory group.
They join the existing advisory committee members Terence Tao and Timothy Gowers, both winners of the Fields Medal, as well as Dan Roberts, Geoff Smith and Po-Shen Loh.
The AIMO Advisory Committee will support the development of the AIMO Prize, including advising on appropriate protocols and technical aspects, and designing the various competitions and prizes.
Simon Coyle, Head of Philanthropy at XTX Markets, commented:
“We are thrilled to complete the AIMO Advisory Committee with the appointments of D., Kevin, Leo, Lester and Peter. Together, they have enormous experience in machine learning and automated reasoning and are already bringing expertise and wisdom to the AIMO Prize. We look forward to announcing the winners of the AIMO’s first Progress Prize soon, and then publicly sharing the AI models to support the open and collaborative development of AI.”
Further information on the AIMO Prize
There will be a grand prize of $5mn for the first publicly shared AI model to enter an AIMO approved competition and perform at a standard equivalent to a gold medal in the IMO. There will also be a series of progress prizes, totalling up to $5mn, for publicly shared AI models that achieve key milestones towards the grand prize.
The first AIMO approved competition opened to participants in April 2024 on the Kaggle competition platform. The first progress prize focuses on problems pitched at junior and high-school level maths competitions. There is a total prize pot of $1.048m for the first progress prize, of which at least $254k will be awarded in July 2024, There will be a presentation of progress held in Bath, England in July 2024, as part of the 65th IMO.
For more information on the AIMO Prize visit: https://aimoprize.com/ or the competition page on Kaggle: https://www.kaggle.com/competitions/ai-mathematical-olympiad-prize/
Advisory Committee member profiles:
D. Sculley
D. is the CEO at Kaggle. Prior to joining Kaggle, he was a director at Google Brain, leading research teams working on robust, responsible, reliable and efficient ML and AI. In his career in ML, he has worked on nearly every aspect of machine learning, and has led both product and research teams including those on some of the most challenging business problems. Some of his well-known work involves ML technical debt, ML education, ML robustness, production-critical ML, and ML for scientific applications such as protein design.
Kevin Buzzard
Kevin a professor of pure mathematics at Imperial College London, specialising in algebraic number theory. As well as his research and teaching, he has a wide range of interests, including being Deputy Head of Pure Mathematics, Co-Director of a CDT and the department’s outreach champion. He is currently focusing on formal proof verification, including being an active participant in the Lean community. From October 2024, he will be leading a project to formalise a 21st century proof of Fermat’s Last Theorem. Before joining Imperial, some 20 years ago, he was a Junior Research Fellow at the University of Cambridge, where he had previously been named ‘Senior Wrangler’ (the highest scoring undergraduate mathematician). He was also a participant in the International Mathematical Olympiad, winning gold with a perfect score in 1987. He has been a visitor at the IAS in Princeton, a visiting lecturer at Harvard, has won several prizes both for research and teaching, and has given lectures all over the world.
Leo de Moura
Leo is a Senior Principal Applied Scientist in the Automated Reasoning Group at AWS. In his spare time, he dedicates himself to serving as the Chief Architect of the Lean FRO, a non-profit organization that he proudly co-founded alongside Sebastian Ullrich. He is also honoured to hold a position on the Board of Directors at the Lean FRO, where he actively contributes to its growth and development. Before joining AWS in 2023, he was a Senior Principal Researcher in the RiSE group at Microsoft Research, where he worked for 17 years starting in 2006. Prior to that, he worked as a Computer Scientist at SRI International. His research areas are automated reasoning, theorem proving, decision procedures, SAT and SMT. He is the main architect of several automated reasoning tools: Lean, Z3, Yices 1.0 and SAL. Leo’s work in automated reasoning has been acknowledged with a series of prestigious awards, including the CAV, Haifa, and Herbrand awards, as well as the Programming Languages Software Award by the ACM. Leo’s work has also been reported in the New York Times and many popular science magazines such as Wired, Quanta, and Nature News.
Lester Mackey
Lester Mackey is a Principal Researcher at Microsoft Research, where he develops machine learning methods, models, and theory for large-scale learning tasks driven by applications from climate forecasting, healthcare, and the social good. Lester moved to Microsoft from Stanford University, where he was an assistant professor of Statistics and, by courtesy, of Computer Science. He earned his PhD in Computer Science and MA in Statistics from UC Berkeley and his BSE in Computer Science from Princeton University. He co-organized the second place team in the Netflix Prize competition for collaborative filtering; won the Prize4Life ALS disease progression prediction challenge; won prizes for temperature and precipitation forecasting in the yearlong real-time Subseasonal Climate Forecast Rodeo; and received best paper, outstanding paper, and best student paper awards from the ACM Conference on Programming Language Design and Implementation, the Conference on Neural Information Processing Systems, and the International Conference on Machine Learning. He is a 2023 MacArthur Fellow, a Fellow of the Institute of Mathematical Statistics, an elected member of the COPSS Leadership Academy, and the recipient of the 2023 Ethel Newbold Prize.
Peter J. Liu
Peter J. Liu is a Research Scientist at Google DeepMind in the San Francisco Bay area, doing machine learning research with a specialisation in language models since 2015 starting in the Google Brain team. He has published and served as area chair in top machine learning and NLP conferences such as ICLR, ICML, NEURIPS, ACL and EMNLP. He also has extensive production experience, including launching the first deep learning model for Gmail Anti-Spam, and using neural network models to detect financial fraud for top banks. He has degrees in Mathematics and Computer Science from the University of Toronto.
About XTX Markets:
XTX Markets is a leading financial technology firm which partners with counterparties, exchanges and e-trading venues globally to provide liquidity in the Equity, FX, Fixed Income and Commodity markets. XTX has over 200 employees based in London, Paris, New York, Mumbai, Yerevan and Singapore. XTX is consistently a top 5 liquidity provider globally in FX (Euromoney 2018-present) and is also the largest European equities (systematic internaliser) liquidity provider (Rosenblatt FY: 2020-2023).
The company’s corporate philanthropy focuses on STEM education and maximum impact giving (alongside an employee matching programme). Since 2017, XTX has donated over £100mn to charities and good causes, establishing it as a major donor in the UK and globally.
In a changing world XTX Markets is at the forefront of making financial markets fairer and more efficient for all.
View original content:https://www.prnewswire.co.uk/news-releases/10-million-artificial-intelligence-mathematical-olympiad-prize-appoints-further-advisory-committee-members-302128542.html
-
Artificial Intelligence4 days ago9fin grows leadership team with VP Content promotion
-
Artificial Intelligence6 days agoAurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Uncategorized3 days agoDeutsche Telekom: Your Trusted Partner for AI Solutions in Business
-
Uncategorized4 days ago
US Pushes for AI Partnerships in UAE to Counter China Influence
-
Uncategorized1 day ago
Cherrypicks Partners with AWS DevAx Leading Cloud Technology Innovation for Hong Kong Enterprises
-
Artificial Intelligence5 days agoRockwell Automation and Microsoft announce significant technology integrations connecting the physical and digital industrial worlds at Hannover Messe 2024
-
Artificial Intelligence5 days agoDahua Technology Showcases “The Road to a Sustainable Future” at Intertraffic Amsterdam 2024
-
Artificial Intelligence4 days ago
New CPS Protection Platform: TXOne Networks Unveils SageOne at GISec Global
